What is Dogwood Therapeutics's net income?

Dogwood Therapeutics (DWTX) reported net income of -$4.99M in Q1 2026.

How has Dogwood Therapeutics's net income changed year-over-year?

Dogwood Therapeutics's net income increased by 54.4% year-over-year, from -$10.92M to -$4.99M.

What is the long-term trend for Dogwood Therapeutics's net income?

Over 4 years (2021 to 2025), Dogwood Therapeutics's net income has grown at a 21.0% compound annual growth rate (CAGR), from -$15.96M to -$34.26M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Dogwood Therapeutics DWTX Net Income

Net Income at other companies

Eli LillyLLY

$7.4B+168%

PfizerPFE

$2.7B-9.3%

Vertex PharmaceuticalsVRTX

$1.03B+59.6%

Collegium Pharmaceutical, Inc.COLL

$14.5M+500%

BioventusBVS

$3.95M+219%

Avanos MedicalAVNS

$5.1M-22.7%

Segments

By segment

See full

Single Reportable-$4.99M+53.6%

Other financials

Income statement

See full

Operating income-$5.1M-14.6%

Net income-$5.0M+54.4%

EPS (diluted)-$0.15+98.2%

Balance sheet

See full

Cash & equivalents$13.2M-24.6%

Total debt$144.9K-24.2%

Total equity$80.6M+1,038%

Total assets$95.2M-1.8%

Cash flow

See full

Operating cash flow-$4.6M+2.0%

Valuation

See full

Market cap$54.14M-57.6%

Enterprise value$41.06M-64.7%

Returns & leverage

See full

Return on equity-64.6%-29.8pp

Debt / equity0×0.0×

Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dogwood Therapeutics's net income?: Dogwood Therapeutics (DWTX) reported net income of -$4.99M in Q1 2026.
How has Dogwood Therapeutics's net income changed year-over-year?: Dogwood Therapeutics's net income increased by 54.4% year-over-year, from -$10.92M to -$4.99M.
What is the long-term trend for Dogwood Therapeutics's net income?: Over 4 years (2021 to 2025), Dogwood Therapeutics's net income has grown at a 21.0% compound annual growth rate (CAGR), from -$15.96M to -$34.26M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.